SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · PMC

Using C. elegans to Find Genes, Mechanisms, and Drugs to Slow Cognitive Decline

Innovation in aging · 2020-01-01

Open accessAbstractOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Abstract Cognitive decline is one of the most important losses of human quality of life with age. To find new treatments that might slow these declines, it is useful to have short-lived, rapidly aging models in which to identify possible treatments. We found that C. elegans also lose their ability to learn and remember with age, along with other neuronal functions (axon regeneration, motility, etc.), and these declines are staved off by reduction in the insulin signaling pathway, which also extends lifespan. Both the mechanisms that regulate neuronal functions and the mechanisms that slow decline are well conserved evolutionarily, suggesting that we can use worms to identify new genes and compounds that might slow decline. Additionally, we have developed new C. elegans models of Parkinson’s and Alzheimer’s diseases, and through genetic, genomic, and metabolic studies we have found new approaches that may slow these declines.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.